Clinical and Translational Research
Copyright ©The Author(s) 2022.
World J Clin Cases. Feb 16, 2022; 10(5): 1485-1497
Published online Feb 16, 2022. doi: 10.12998/wjcc.v10.i5.1485
Table 1 Baseline characteristics of patients diagnosed with gastric cancer (n = 35, 492) by prior cancer status
Characteristics
No previous cancer, n = 31491 (88.73%)
With prior cancer, n = 4001 (11.27%)
P value
Age (yr)< 0.001
< 6513160(41.79%)714(17.85%)
≥ 6518331 (58.21%)3287(82.15%)
Sex< 0.001
Male19479 (61.86%)2777(69.41%)
Female12012 (38.14%)1224(30.59%)
Race< 0.001
White22087 (70.14%)2926(73.13%)
Black4090 (12.99%)555(13.87%)
AI/AN285 (0.91%)16(0.4%)
AP4898 (15.55%)504(12.6%)
Unknown131 (0.42%)0(0%)
Marital status< 0.001
Married17571 (55.80%)2366(59.14%)
Unmarried12473 (39.61%)1416(35.39%)
Unknown1447 (4.59%)219(5.47%)
Site
Cardia and Fundus10537 (33.46%)1486(37.14%)
Body of stomach6340 (20.13%)844(21.09%)
Antrum and Pylorus7370 (23.40%)862(21.54%)
Stomach, NOS7244 (23.00%)809(20.22%)
Lymph nodes examined< 0.001
No examined16884 (53.62%)2287(57.16%)
1-157020 (22.29%)909(22.72%)
≥ 166338 (20.13%)686(17.15%)
Unknown1249 (3.97%)119(2.97%)
Positive lymph nodes< 0.001
04914 (36.79%)693(43.45%)
1-22599 (19.46%)327(20.50%)
3-62399 (17.96%)276(17.30%)
7-152355 (17.63%)207(12.98%)
≥ 161066 (7.98%) 89(5.58%)
Unknown25 (0.19%)3(0.19%)
SEER stage< 0.001
Localized7209 (22.89%)1190(29.74%)
Regional8978 (28.51%)1051(26.27%)
Distant12615 (40.06%)1242(31.04%)
Unstaged2689 (8.54%)518(12.95%)
Grade< 0.001
G11087 (3.45%)181(4.52%)
G27012 (22.27%)1027(25.67%)
G318112 (57.51%)2108(52.69%)
G4567 (1.80%)68(1.70%)
Unknown4713 (14.97%)617(15.42%)
Surgery0.088
No16692 (53.01%)2194(54.84%)
Yes14630 (46.46%)1785(44.61%)
Unknown169 (0.54%)22(0.55%)
Radiation< 0.001
None23413 (74.35 %)3098(77.43%)
Radiation7789 (24.73%)866(21.64%)
Unknown289 (0.92%)37(0.92%)
Chemotherapy< 0.001
No/Known17189 (54.58%)2569(64.21%)
Chemotherapy14302 (45.42%)1432(35.79%)